Herbas VPB

Print
EN | LT
Supplementary protection
LT - Anti-PD-L1 antikūnai ir jų panaudojimas T ląstelių funkcijos pagerinimui
EN - ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION
SPC
(11) Number of the document C 2376535
(68) Number of the document 2376535
(21) Application number for Supplementary Protection Certificate PA 2017 041
(22) Date of filing the application 2017-12-19
(41) Date of publication of the application 2018-01-10
Date of publication of SPC 2019-05-10
(24) Date of coming into effect of SPC 2029-12-09
Applicant
(71) F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, CH
Grantee
(73) F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/17/1220, 2017-09-21
Calculated date of expiry of the SPC
(94) 2032-09-25
Name of the product protected by the basic patent
(95) Atezolizumabas
Legal status
SPC revoked (the basic patent revoked after opposition at the EPO)
Date of negative decision to issue the SPC 2022-12-20
Last update date 2023-05-09